Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
S

Shree Ganesh BioTech India Ltd
BSE:539470

Watchlist Manager
Shree Ganesh BioTech India Ltd
BSE:539470
Watchlist
Price: 0.61 INR -3.17% Market Closed
Market Cap: ₹243.2m
Write Note Create Alert Ask AI

Shree Ganesh BioTech India Ltd
Investor Relations

Shree Ganesh Biotech (India) Ltd. is a biotech firm, which engages in the production, processing, and marketing of hybrid seeds. The company is headquartered in Kolkata, West Bengal. The company went IPO on 2015-11-24. The firm is also involved in the business of tissue culture plant. The company is a provider of crop solutions to the farmer by supplying high yielding hybrid seeds and crop management, namely micronutrients and bioproducts. The firm is also engaged in research and development in the areas of superior breeding programs and biotechnology tools. The firm sells its products to the farmers in West Bengal, Odisha and Bihar.

Show more
Loading
539470
BSE Sensex 30
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Contacts

Address
WEST BENGAL
Kolkata
6Th Floor, Premises 602, Mahavir Apartment 2, Ashutosh Mukherjee Road
Contacts
+913323988213
www.shreeganeshbiotech.club
sparklesyt

See Also

Summary
SHREEGANES intrinsic value, competitors valuation, and company profile.
DCF Valuation
SHREEGANES stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SHREEGANES stock valuation using valuation multiples.
Wall Street Estimates
SHREEGANES price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SHREEGANES stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 321,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett